Food and Drug Administration (FDA) Commissioner Martin Makary said on Thursday he has “no plans to take action” to restrict the availability of mifepristone, the first drug used in a two-drug medication abortion regimen.
Makary made the remark on Thursday while speaking at the Semafor World Economy Summit, the outlet reported.
“Speaking at the Semafor World Economy Summit, Makary took a firmer stance on the issue than he did in his Senate confirmation hearing last month, when he said he would ‘do a review of the data’ and didn’t commit to specific action — leading some to wonder whether the Donald Trump administration would ultimately move to roll back access to the pill,” the report states.
Makary did say there is a possibility
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!